MedPath

evaluation of intermittent docetaxel chemotherapy in patients with castration-resistant prostate cancer

Not Applicable
Conditions
prostate cancer
Registration Number
JPRN-UMIN000007044
Lead Sponsor
Cancer Insutitute in Hyogo prefecture
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. patients with active other malignancies at the time of enrollment 2. patients with brain or meningeal metastasis at the time of enrollment 3. patients with nerve disorder more than grade 2 in CTCAE ver4.0 (except for owing to tumor compression) 4. patients with edema more than grade 2 in CTCAE ver4.0 5. patients with pleural effusion, ascites or pericardial effusion that need medical attention 6. patients with allergy to polysorbate80 7. patients with other sever complications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath